Inventor · disambiguated record
Kim Louise Hirst
Also filed as: HIRST KIM · HIRST KIM LOUISE
16 granted patents·10 pending applications·51 citations·filing 2007–2024
91Inventor score
Files withASTEX THERAPEUTICS LTD10ANDREWS MARTIN JAMES INGLIS5CHIESI FARM SPA2GALAPAGOS NV2ONO PHARMACEUTICAL CO2
Top patents by PatentIndex Score
26 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0292US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0392US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0489US7915256B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Mar 29, 2011·12 cites·50 claims
- 0589US7501411B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2007·Granted Mar 10, 2009·12 cites·54 claims
- 0685US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 0784US12077526B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2023·Granted Sep 3, 2024·1 cites·22 claims
- 0882US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0979US11603367B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2018·Granted Mar 14, 2023·2 cites·12 claims
- 1077US7893058B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 22, 2011·2 cites·55 claims
- 1170US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 1270US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1367US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1460US2024199624A1Compounds, compositions, and methodsCHDI FOUNDATION INC·Filed 2023·Application pending·0 cites
- 1557US8148369B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2008·Granted Apr 3, 2012·0 cites·62 claims
- 1654US8173656B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted May 8, 2012·0 cites·12 claims
- 1754US2011130405A1Substituted quinazolines as blood platelet lowering agentsSHIRE LLC·Filed 2009·Application pending·0 cites
- 1853US2024279221A1Heterocyclic compounds and methods of useSCHROEDINGER INC·Filed 2022·Application pending·0 cites
- 1952US8178530B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted May 15, 2012·0 cites·53 claims
- 2050US2011065714A1Substituted quinazolinesSHIRE LLC·Filed 2009·Application pending·0 cites
- 2149US9006237B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2012·Granted Apr 14, 2015·0 cites·62 claims
- 2249US2011178067A1Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2011·Application pending·0 cites
- 2348US2024025880A1Amino quinazoline derivatives as p2x3 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2447US2018289718A1Fused imidazole compoundsONO PHARMACEUTICAL CO·Filed 2018·Application pending·0 cites
- 2543US12466820B2Amino quinazoline derivatives as P2X3 inhibitorsCHIESI FARM SPA·Filed 2020·Granted Nov 11, 2025·0 cites·9 claims
- 2639US10016439B2Fused imidazole compoundsONO PHARMACEUTICAL CO·Filed 2015·Granted Jul 10, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Kim Louise Hirst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →